Navigation Links
Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference
Date:10/24/2007

- favorable pharmacokinetic and safety data observed in first clinical

trial of novel Fleximer(TM) anticancer agent -

CAMBRIDGE, Mass., Oct. 24 /PRNewswire/ -- Mersana, a cancer therapeutics company, announced interim results of a Phase I study of its lead product candidate, XMT-1001, in patients with advanced solid tumors. The data was presented by Edward A. Sausville, M.D., Ph.D, Professor of Medicine and Associate Director for Clinical Research, University of Maryland Greenebaum Cancer Center in a poster session on October 23 at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Therapeutics taking place in San Francisco, CA. Full text of the abstract #A146 "A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients with Advanced Solid Tumors" can be viewed online at the AACR website at http://www.aacr.org. XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity.

Commenting on the data, Robert J. Fram, M.D. Chief Medical Officer at Mersana, stated: "The Phase I results show that, in humans, camptothecin, the active agent in XMT-1001, is released gradually from the Fleximer carrier as a pro-drug in a manner that will potentially avoid common safety problems associated with drugs in this class. To date, we've seen no evidence of drug-related serious adverse events and the study is ongoing."

Results were presented from 12 patients enrolled in an ongoing Phase I open-label, dose-escalation trial designed to determine the safety, tolerability and pharmacokinetic profile of XMT-1001. To date, XMT-1001 has been well tolerated in patients and no serious drug related adverse events have been reported. Preliminary results demonstrate a favorable pharmacokinetic profile with low levels of CPT, both total and free, recovered in urine. The ma
'/>"/>

SOURCE Mersana Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  ACI Clinical ( ... independent Data Monitoring Committees. Using this ... percent over industry standard costs and receive the ... leader in committee services. Leveraging a ... and contracting, charter development, statistical programming and meeting ...
(Date:8/21/2014)... , Aug. 21, 2014 CVS Caremark Corporation ... results, applicable Reference Yields and consideration payable in connection with ... on August 7, 2014 for (1) any and all of ... Notes") and (2) up to a maximum amount of its ... and 5.750% Senior Notes due 2017 (collectively, the "Maximum Tender ...
(Date:8/21/2014)... Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ... 2014.  Quarterly highlights 1   ... to the first quarter of fiscal 2014, and other achievements, ... an increase of 6.8%; , Strong international net sales ... currency basis; , U.S. net product sales reached a ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
... A combination of three drugs used worldwide as the standard ... danger of death or hospitalization, and should not be used ... to the surprising results of a rigorous independent study. ... the New England Journal of Medicine to coincide ...
... /PRNewswire-iReach/ -- Denton Vacuum LLC, a leading ... new website that guides visitors to information ... and navigation mirror what it,s like to work with ... business and technical drivers," says Rod Moore, Denton,s president. ...
Cached Medicine Technology:First, do no harm: Study finds danger in standard treatment for a serious lung disease 2First, do no harm: Study finds danger in standard treatment for a serious lung disease 3First, do no harm: Study finds danger in standard treatment for a serious lung disease 4Denton Vacuum's New Website Organizes Thin-Film Technology Information By Industry 2
(Date:8/22/2014)... August 22, 2014 The world’s largest, ... recently registered its two millionth member, and it has ... , Billionairefish.com is a dating website for the rich ... date. The dating website caters like-minded people who are ... site for the rich , this is the place ...
(Date:8/22/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Diamondback 360 Peripheral ... announced on August 19, that certain lots of the ... (Part number 7-10003), by Cardiovascular Systems, are recalled ... could fracture during use and could possibly block blood ...
(Date:8/22/2014)... 22, 2014 On October 10, ... Canada to present an in-depth workshop on mindfulness ... headquarters. In the one-day workshop, participants will learn ... their biofeedback practice. , According to Dr. Khazan, ... help people control their physiological responses. However, extensive ...
(Date:8/22/2014)... to naysayers who are being skeptical about the success ... therapy LA specialist has firmly stated that the new ... well researched science and nothing to do with medical ... breakthrough technology which focuses on healing and repair of ... The Managing Director of one of the top PRP ...
(Date:8/22/2014)... Top10BestSEOHosting.com has recently compared many SEO hosting ... is one of the most recommended suppliers for ... hosting products. , Top10BestSEOHosting.com’s researchers look at ... technology, product availability and online service, ease of ... , “We believe that JustHost is one ...
Breaking Medicine News(10 mins):Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 2Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 3Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2
... , SATURDAY, March 17 (HealthDay News) -- Teens and young ... other time may be risking brain damage, an expert warns. ... of four alcoholic drinks by males and three drinks by ... dependency or addiction, said Dr. Alicia Ann Kowalchuk, medical director ...
... Medical Center is one of the major enrollers in a ... the heart works no better than drugs in preventing strokes. ... of Medicine . Loyola enrolled 24 patients, one of the ... any other Chicago-area hospital. Principal investigators at the Loyola site ...
... , FRIDAY, March 16 (HealthDay News) -- Musicians and ... relationship can hit a sour note: Certain parts of musical ... condition called contact dermatitis, an expert warns. Contact dermatitis ... which skin becomes red, scaly and inflamed. Some components of ...
... , FRIDAY, March 16 (HealthDay News) -- Among people with ... risk of death during a seven-year study period, researchers found. ... placed in a coronary artery to keep it open. Coronary ... 1,234 coronary-artery-disease patients in the Netherlands with an average age ...
... March 21, the Congressional Brain Injury Task Force brings representatives ... Injury Awareness (BIA) Day. The day starts with the BIA ... and screening and care and rehabilitation. The afternoon features a ... One, Any Age." William A.B. Ditto, MSW, ...
... assisted reproduction are no longer experimental procedures. In some ... are conceived by IVF, and in every kindergarten classroom there ... Assisted reproduction is the solution to today,s epidemic of infertility. ... and Society by Bart Fauser and Paul Devroey (Oxford | ...
Cached Medicine News:Health News:Spring Break Boozing May Put Young Brains at Risk 2Health News:Closing hole in the heart no better than drugs in preventing strokes 2Health News:Tooting Your Horn Can Raise Risk for Skin Condition 2Health News:Depression Tied to Earlier Death in Heart Patients 2Health News:Kessler Foundation neuroscientist to speak at Brain Injury Awareness Day on Capitol Hill 2Health News:'Baby-making' 2
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Inquire...
Medicine Products: